Literature DB >> 15914612

Eye movements in chorea-acanthocytosis.

Libe Gradstein1, Adrian Danek, Jordan Grafman, Edmond J Fitzgibbon.   

Abstract

PURPOSE: To describe the eye movement abnormalities in patients with chorea-acanthocytosis (ChAc), a form of neuroacanthocytosis. This autosomal recessive, neurodegenerative disorder with aberrant erythrocyte morphology (acanthocytosis) is caused by mutations in the VPS13A gene. In contrast to Huntington's disease (for which ChAc has occasionally been mistaken), ocular involvement in ChAc has not been systematically studied.
METHODS: Three patients aged 26, 30, and 44 years with ChAc and six normal volunteers aged 31 to 48 years were included. Patients had dystonia, chorea, parkinsonism, dysarthria, dysphagia, seizures, cognitive abnormalities, and acanthocytosis. All had heterozygous VPS13A mutations and degeneration of the basal ganglia on magnetic resonance imaging (MRI) typical of ChAc. Patients had an extensive clinical and laboratory work-up. Neuro-ophthalmic examinations and eye movement recordings made with the magnetic search coil technique assessed patients' fixation characteristics, horizontal and vertical saccades, pursuit, and antisaccades. These were compared to the data of control subjects.
RESULTS: Patients exhibited more than 30 square-wave jerks (small saccadic intrusions) per minute, versus 0 to 8 in the control subjects, as well as fractionated (multistep) and hypometric horizontal and vertical saccades. Decreased saccadic peak-velocity and reduced saccadic range were more pronounced for vertical saccades. Pursuit testing performed in two patients showed low gain. Results of antisaccade testing done in one patient were abnormal.
CONCLUSIONS: The findings suggest brain stem involvement as an additional site of neurodegeneration outside the basal ganglia in ChAc. Patients with this progressive, intractable disease have pronounced ocular motor abnormalities. Eye movement recordings could assist in diagnosing ChAc, monitoring its progression and possible treatment evaluation.

Entities:  

Mesh:

Year:  2005        PMID: 15914612     DOI: 10.1167/iovs.04-0539

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

Review 1.  Vertical supranuclear gaze palsy in Niemann-Pick type C disease.

Authors:  Ettore Salsano; Chizoba Umeh; Alessandra Rufa; Davide Pareyson; David S Zee
Journal:  Neurol Sci       Date:  2012-07-19       Impact factor: 3.307

2.  Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis.

Authors:  Carol Dobson-Stone; Antonio Velayos-Baeza; An Jansen; Frederick Andermann; François Dubeau; Francine Robert; Anne Summers; Anthony E Lang; Sylvain Chouinard; Adrian Danek; Eva Andermann; Anthony P Monaco
Journal:  Neurogenetics       Date:  2005-09-28       Impact factor: 2.660

3.  Automatic striatal volumetry allows for identification of patients with chorea-acanthocytosis at single subject level.

Authors:  Hans-Jürgen Huppertz; Judith Kröll-Seger; Adrian Danek; Bernd Weber; Thomas Dorn; Jan Kassubek
Journal:  J Neural Transm (Vienna)       Date:  2008-07-22       Impact factor: 3.575

4.  The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician.

Authors:  Davide Martino; Maria Stamelou; Kailash P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-19       Impact factor: 10.154

Review 5.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

Review 6.  The diagnostic value of saccades in movement disorder patients: a practical guide and review.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Janet C Rucker; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2015-10-15

7.  Unraveling the Spatiotemporal Distribution of VPS13A in the Mouse Brain.

Authors:  Esther García-García; Nerea Chaparro-Cabanillas; Albert Coll-Manzano; Maria Carreras-Caballé; Albert Giralt; Daniel Del Toro; Jordi Alberch; Mercè Masana; Manuel J Rodríguez
Journal:  Int J Mol Sci       Date:  2021-12-01       Impact factor: 5.923

8.  Clinical and molecular research of neuroacanthocytosis.

Authors:  Lihong Zhang; Suping Wang; Jianwen Lin
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

Review 9.  Novel Imaging Biomarkers for Huntington's Disease and Other Hereditary Choreas.

Authors:  Patrik Fazio; Martin Paucar; Per Svenningsson; Andrea Varrone
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-05       Impact factor: 5.081

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.